| Name |
Teynofor 245 mg filmom obložene tablete |
| Former Name |
Tenofovirdizoproksil Alpha-Medical 245 mg filmom obložene tablete |
| Marketing Authorisation Number |
HR-H-529695861 |
| Active Substance |
tenofovirdizoproksilsukcinat |
| Composition |
jedna filmom obložena tableta sadrži 245 mg tenofovirdizoproksila (u obliku tenofovirdizoproksilsukcinata) |
| Pharmaceutical Form |
filmom obložena tableta |
| Manufacturer |
Remedica Ltd., Limassol, Cipar |
| Marketing Authorisation Holder |
Alpha-Medical d.o.o., Dragutina Golika 36, Zagreb, Hrvatska |
| Marketing Authorisation Date |
23.10.2023 |
| MA Period of Validity |
unlimited |
| Classification Number |
UP/I-530-09/21-02/47 |
| Registration Number |
381-12-01/70-23-20 |
| Prescription |
Medicinal product subject to medical prescription |
| Type of prescription |
ograničeni recept
|
| Distribution |
Supply through pharmacies (community) |
| Advertising to general public |
not allowed |
| ATC Code |
J05AF07 |
| Marketing status |
stavljeno u promet |
| Shortage status |
nema nestašice |
| SmPC |
download |
| PL |
download |
| Public Assessment Report |
download
|
